Corporate R&D

DAWN Pharmaceuticals Co., Ltd. has a precise understanding of international trends in new drug development, allowing it to swiftly identify high-cost-performance drugs suitable for a broad range of patients. Leveraging its strong resource integration capabilities, Bangladesh's significant advantages in the pharmaceutical generic sector, and policy support from the international community for the Bangladeshi pharmaceutical industry, we can quickly organize professional scientific teams to advance drugs into mass production.

All drugs produced by the company undergo rigorous inspection by the Drug Administration to ensure their quality and safety. Moreover, all company products are manufactured in facilities certified to meet World Health Organization (WHO) standards. These high-standard quality control measures guarantee the safety, efficacy, and compliance of every batch of medication.

The company has a global sales network and an efficient pharmaceutical logistics system, ensuring that medications reach patients promptly, fulfilling their treatment needs in a timely manner. This comprehensive system further highlights the company's competitive advantage in the global pharmaceutical market.

1. Core Focus Areas:

The core mission of DAWN Pharmaceuticals Co., Ltd. is to produce FDA and internationally recognized targeted drugs for specific diseases to serve patients worldwide. We focus on the following areas:

- Cancer Treatment: Developing targeted drugs that identify and attack cancer cells while minimizing harm to healthy cells.

- Autoimmune Diseases: Researching specific target molecules to effectively treat various autoimmune diseases by regulating the immune system.

- Rare Disease Treatment: Utilizing gene editing technologies and targeted therapies to develop treatments for rare diseases affecting small populations.

- Personalized Medicine: Designing personalized targeted drugs based on patients’ genetic information, medical history, and other health data to optimize treatment outcomes.

 2. Quality Assurance:

The company strictly enforces quality control standards across all partner manufacturing processes to ensure that all stages of drug research, development, and production meet international standards:

- Drug Screening: All produced and preventive drugs must be approved by authoritative international agencies such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) before entering production.

- API Selection: Active Pharmaceutical Ingredient (API) suppliers must have comprehensive and internationally compliant production systems to ensure that their raw materials meet stringent quality requirements.

- Sample Testing: API materials must be sent to the Bangladesh Drug Administration for ingredient analysis and testing, and only those meeting quality standards are deemed qualified raw materials for drug production.

- Finished Product Testing: All finished pharmaceutical products must pass the stringent tests of the Bangladesh Drug Administration, and their quality parameters must meet the standards of internationally recognized testing agencies before entering the market.

This comprehensive and systematic quality assurance system ensures that drugs are safe, effective, and compliant at every stage, from production to testing to market distribution, enhancing the company's credibility and reputation in the global market.

 3. Logistics Support:

Through strong resource integration, the company has established an efficient and extensive pharmaceutical logistics network, ensuring the timely delivery of medications worldwide. We not only have deep cooperation with leading international logistics companies but have also built an internal coordination mechanism to optimize transport processes and improve delivery efficiency.

- Wide Coverage: Our logistics network covers major markets worldwide. Whether for domestic or international markets, especially Southeast Asia, we ensure safe and rapid delivery of drugs to their destinations.

- Cold Chain Transport: For drugs requiring special storage and transportation conditions, we are equipped with advanced cold chain technologies to ensure temperature control throughout, maintaining drug safety and efficacy.

- Emergency Response Capability: The company has robust emergency logistics capabilities, enabling the swift allocation of resources to ensure the timely supply of medications to patients in the event of emergencies or urgent needs.

This comprehensive logistics support system not only ensures the timely and safe delivery of drugs to patients worldwide but also significantly improves the company's operational efficiency and market responsiveness, providing strong support for patient health.